The number of people with susceptibility test result for rifampicin in Mongolia
Mongolia: The number of people with susceptibility test result for rifampicin was 1,106 in 2021. ▲ Rising
Latest (2021)
1,106
Change on year
down 31.4%
World rank
64th
of 155 countries
All-time high
1,612
in 2020
All-time low
971
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Mongolia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Mongolia stood at 1,106.
Compared with earlier readings it is down 31.4% on the previous year and up 13.9% over five years.
Mongolia ranks 64th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Mongolia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 971 | — |
| 2018 | 1,242 | +27.9% |
| 2019 | 1,491 | +20.0% |
| 2020 | 1,612 | +8.1% |
| 2021 | 1,106 | -31.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,235 | 971 | 1,491 | 3 |
| 2020s | 1,359 | 1,106 | 1,612 | 2 |
Countries ranked near Mongolia
More health data for Mongolia
- Un projection of annual infant deaths, annual growth rate -1.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6056 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 847.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 63 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.44 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0458 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.5 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Mongolia?
- The number of people with susceptibility test result for rifampicin in Mongolia was 1,106 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Mongolia?
- The highest recorded value was 1,612 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Mongolia?
- The lowest recorded value was 971 in 2017.
- How does Mongolia rank for the number of people with susceptibility test result for rifampicin?
- Mongolia ranks 64th out of 155 countries with data for 2021.
- Where does this Mongolia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).